Extracorporeal elimination in acute valproate intoxication

Area of Science:

• Clinical Toxicology
• Nephrology
• Pharmacokinetics

Background:

• Severe valproate poisoning can lead to coma and death.
• Valproate's pharmacokinetic properties (low renal excretion, high protein binding) typically make it resistant to extracorporeal elimination.
• Despite these properties, case reports suggest extracorporeal methods can be effective.

Purpose of the Study:

• To describe the successful management of a massive valproate overdose.
• To evaluate the efficacy of hemodialysis and continuous venovenous hemodiafiltration (CVVH-D) in severe valproate intoxication.
• To review existing literature on extracorporeal treatments for valproate overdose.

Main Methods:

• A 57-year-old male patient ingested 64 g of valproate.
• Initial treatment involved 6 hours of hemodialysis.
• Hemodialysis was followed by 18 hours of continuous venovenous hemodiafiltration (CVVH-D) to prevent rebound toxicity.

Main Results:

• The patient with massive valproate overdose was successfully treated.
• Hemodialysis effectively removed valproate, and subsequent CVVH-D prevented a resurgence of toxicity.
• Literature review supports the benefit of these combined extracorporeal methods.

Conclusions:

• Hemodialysis is a beneficial treatment for severe valproate overdose.
• Combining hemodialysis with continuous venovenous hemodiafiltration (CVVH-D) is the recommended treatment strategy for serious valproate intoxication.
• Extracorporeal elimination can be effective even with unfavorable pharmacokinetic profiles.